TWEAK induces liver progenitor cell proliferation

Aniela Jakubowski, Christine Ambrose, Michael Parr, +9

Journal of Clinical Investigation

T-regulatory CellApoptosisImmunologyCell DeathPathology +18

TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration

Mahasweta Girgenrath, Shawn Weng, Christine A. Kostek, +14

The EMBO Journal

Regenerative MedicineSkeletal Muscle RegenerationReceptor Fn14Developmental BiologyBone Morphogenic Protein +9

TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease

Bhanu P. Pappu, Anna Borodovsky, Timothy S. Zheng, +13

The Journal of Experimental Medicine

Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells

Sean Campbell, Linda C. Burkly, Hua-Xin Gao, +7

The Journal of Immunology

TWEAK Is a Novel Arthritogenic Mediator

Stuart J. Perper, Beth Browning, Linda C. Burkly, +13

The Journal of Immunology

ImmunologyCell DeathImmunotherapyOrthopaedic SurgeryInflammation +14

Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)

Pascal Schneider, Dian L. Olson, Aubry Tardivel, +11

Journal of Biological Chemistry

Dual role for TWEAK in angiogenic regulation

Aniela Jakubowski, Beth Browning, Matvey Lukashev, +7

Journal of Cell Science

Endothelial CellsImmunologyTumor BiologyInflammationAngiogenesis +16

Tweak induces mammary epithelial branching morphogenesis

Jennifer S. Michaelson, Sandy Cho, Beth Browning, +5

Oncogene

Cell LineageDevelopmental BiologyMammary GlandMorphogenesisEpithelial-mesenchymal Interactions +5

A Humanized Form of a CD4-Specific Monoclonal Antibody Exhibits Decreased Antigenicity and Prolonged Plasma Half-Life in Rhesus Monkeys While Retaining Its Unique Biological and Antiviral Properties

Keith A. Reimann, Wenyu Lin, Beth Browning, +9

AIDS Research and Human Retroviruses

Humoral ResponseImmunologyCd4 T Cell ResponsesAntiviral DrugCd4+ Cell +17

Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders

John Malona, Claudio Chuaqui, Boris M. Seletsky, +18

Translational research